All pot stocks are not Tilray – and that's a good thing, says the CEO of his competitor Canopy Growth.

"I think it has become technically bizarre."

Investors should not leave the stock of Tilray Inc. jars

TLRY, -30.25%

The wild trading week is diverting them from the marijuana sector, the rival of cannabis rival Canopy Growth Corp.

GSC -5.00%

CEO Bruce Linton said Friday on CNBC.

The nascent sector is much more stable than the titles of Tilray, Linton insists, after the Nasdaq had to stop trading with Tilray five times in Wednesday's session.

There are approximately 76.5 million Tilray shares in circulation, but the float – these shares actually available for trading – represents only 17.8 million, according to FactSet, which calls for increased volatility. This means that Tilray is not the representative of the sector that Wall Street intends to be, Linton argued.

Shares of Canadian marijuana companies were put to the test this week after the US Drug Enforcement Administration approved Tilray's plan to import a medical cannabis product. Tilray, the first title to be published on the Nasdaq, jumped nearly 30% in response to the regulatory hurdle. Still, it closed down 30% Friday to cap the wild week.

Until now, the news of Tilray become largely the news of this young sector, causing an obsession for the stock of cannabis. The company's data rose 215% last month, according to data from FactSet.

Do not miss: Have you missed the wild race in Tilray's stocks and you want to invest in cannabis? Beware of rogue players

"I suspect [Tilray trading] will return to normal. It's a good thing. They have a good start, "Linton said in the interview.

Canopy shares, listed on the New York Stock Exchange, are trading "relatively normal," he said. The stock fell 5% Friday; it rose 110% to 2018 and about 487% last year.

It's a booming industry, and market developments are sure to help, thanks to Tilray or its competitors. In addition to Canopy and Tilray, the publicly traded sector of the sector includes Aurora Cannabis Inc.

CBA -3.35%

and Cronos group

CRON, -9.02%

Aleafia Health Inc. stock

ALEF, + 18.32%

surged 18% on Friday after announcing added to Horizons Marijuana Life Sciences Exchange Traded Fund

HMMJ, -3.89%

.

Even the liquor is about Molson Coors Brewing Co.

TAP, -0.22%

and Diageo

WD + 0.28%

they intensify through partnerships. And there is market speculation that Coca-Cola Co.

KO -0.13%

is interested in Denver's New Age beverages, which make cannabidiol-based drinks or CBD, such as the drink called "Mellow Mood".

Lily : The grass beer is near and it will become weird